GlassScriptPhysician profile
Austin Taylor
NPI 1902031388
$4,524.08
in general payments reported to CMS, 2019-2025
20 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,568 · 2020: $55.71 · 2021: $1,163 · 2022: $322 · 2023: $288 · 2024: $25.38 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,410.56 | 2019-2024 | |
| Stryker Corporation | $888.24 | 2019-2025 | Gamma, Pangea |
| Arthrex, INC. | $846.48 | 2019 | |
| Zimmer Biomet Holdings, INC. | $750.44 | 2021 | |
| Vericel Corporation | $106.42 | 2021 | |
| Masimo Corporation | $87.28 | 2023 | Set and Rainbow Set |
| Dynasplint Systems INC. | $81.48 | 2019 | |
| Genzyme Corporation | $69.17 | 2019 | |
| Novartis Pharmaceuticals Corporation | $43.14 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $42.75 | 2022-2025 | Zilretta |
| Smith+Nephew, INC. | $39.26 | 2022 | |
| Anika Therapeutics, INC. | $31.29 | 2025 | Integrity Implant |
| Innovation Technologies INC | $24.85 | 2023 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $16.80 | 2025 | |
| Ethicon US, LLC | $16.71 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $16.53 | 2020 | |
| Avanos Medical | $13.65 | 2021 | |
| Pacira Therapeutics, INC. | $13.19 | 2020 | |
| Bioventus LLC | $13.02 | 2023 | Durolane |
| Kowa Pharmaceuticals America, INC. | $12.82 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.